Welcome to our dedicated page for Afya news (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya stock.
Afya Limited (Nasdaq: AFYA) is the leading medical education and digital health services provider in Brazil. Through its subsidiaries, Afya offers a comprehensive range of educational products and services, including medical schools, residency preparatory courses, and continuing education programs. Catering to lifelong medical learners, Afya operates across various disciplines such as medicine, dentistry, nursing, psychology, pharmacy, and more. The company also provides digital services like clinical decision software, practice management tools, and telemedicine solutions, supporting healthcare professionals at every stage of their careers. With substantial growth and significant market presence, Afya is committed to enhancing medical education and healthcare delivery throughout Brazil.
Afya Limited (Nasdaq: AFYA) has received authorization from Brazil's Ministry of Education to operate a new medical school in Garanhuns, Pernambuco. This approval allows ITPAC, a subsidiary, to expand operations and provide 120 medical seats, translating to a purchase price of R$108 million, with half payable at closing and the remainder in two annual installments. This move aligns with Afya's goal of being a leading medical education provider in Brazil.
Afya Limited (NASDAQ: AFYA) is set to report its third quarter 2021 financial results for the period ending September 30, 2021, after market close on November 22, 2021. Following this, a conference call and webcast will be hosted at 5:00 PM EDT on the same day, allowing investors to gain insights into the company's performance. Investors can access the webcast live or in archive form on the company's Investor Relations website.
Afya Limited (NASDAQ: AFYA) announced a new share repurchase program allowing the purchase of up to 1,383,108 Class A common shares starting October 28, 2021, until December 31, 2022. This follows a previous program where 1,015,844 shares were repurchased. The initiative aims to utilize existing funds, and repurchases will be executed based on market conditions. Afya also appointed BofA Securities as the purchasing agent, adhering to SEC Rule 10b-18 to ensure compliance.
Afya Limited (NASDAQ: AFYA) has acquired 100% of RX PRO, a service facilitating connections between physicians and the pharmaceutical industry. RX PRO's innovative platform has reached over 45,000 physicians and is currently utilized by more than 12 pharmaceutical companies, forecasting a gross revenue of R$8.9 million for 2021. The acquisition cost R$35.4 million, with 85% paid in cash and the rest in Afya shares, plus an earn-out potential of R$21 million based on future revenue targets.
Afya Limited (Nasdaq: AFYA) reported robust financial results for Q2 and H1 2021, with adjusted net revenue of R$381.5 million, up 39.1% YoY, and R$784.0 million for H1, rising 43.5% YoY. Adjusted EBITDA also increased to R$160.7 million (42.1% margin) for Q2 and R$368.3 million (47.0% margin) for H1. However, adjusted net income fell 27.3% to R$65.1 million. Cash flow from operations surged 70.0% to R$343.2 million, aided by a strong cash position of R$1.4 billion. Afya continues its digital strategy with new acquisitions, targeting sustainable growth and increased market penetration.
Afya Limited (Nasdaq: AFYA) has announced it will report its second quarter 2021 financial results for the period ended June 30, 2021, after market close on August 26, 2021. This announcement rectifies a previous press release dated July 19, 2021. A conference call and webcast will be held on the same day at 5:00 PM EDT. The company is recognized as a leading medical education group in Brazil, offering a comprehensive ecosystem to support medical students through various stages of their training.
Afya Limited (Nasdaq: AFYA) has announced the sale of 23,074,134 Class B common shares by Crescera Educacional to an affiliate of Bertelsmann SE & Co. KGaA. Bertelsmann has held a stake in Afya since inception through Crescera and had a representative on Afya’s board since 2019. Following the transaction, Crescera board members Daniel Borghi and Laura Guaraná have left, while Bertelsmann appointed Shobhna Mohn and Kay Krafft to the board. Mohn brings extensive VC experience, and Krafft has a background in M&A and strategic investments.
Afya Limited (Nasdaq: AFYA) has successfully closed the acquisition of Companhia Nilza Cordeiro Herdy de Eduação e Cultura (UNIGRANRIO) for an enterprise value of R$700 million, including R$73.9 million in net debt. The payment structure consists of 60% in cash and 40% in four annual installments. This acquisition enhances Afya's educational capacity, adding 308 medical school seats and increasing total medical seats to 2,611, projecting a net revenue of R$343.2 million for 2023. The acquisition is expected to boost margins and deliver a 9% CAGR in medical student enrollment by 2026.
Afya Limited (Nasdaq: AFYA) successfully held its Annual General Meeting on July 23, 2021, where shareholders approved key resolutions. These included the ratification of financial statements for the fiscal year ending December 31, 2020, and the approval of an Amended and Restated Memorandum and Articles of Association. These changes are in accordance with a share purchase agreement established on June 7, 2021, with Crescera Educacional II and Erste WV Gtersloh Gmbh. Afya is a prominent medical education group in Brazil, focusing on enhancing medical students' and physicians' experiences.
FAQ
What is the current stock price of Afya (AFYA)?
What is the market cap of Afya (AFYA)?
What services does Afya Limited offer?
In which areas does Afya Limited operate?
How has Afya Limited performed financially?
What digital services does Afya Limited provide?
How does Afya support medical professionals?
Where is Afya Limited based?
What are some recent achievements of Afya Limited?
What is Afya's approach to sustainability and ESG?
How extensive is Afya’s digital health services footprint?